New Take On Growth Factor Signaling In Tamoxifen Resistance
Tuesday, June 30, 2009 - 09:21
in Health & Medicine
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.
Read the whole article on Science Daily
More from Science Daily
Related
- A new take on growth factor signaling in tamoxifen resistanceTue, 23 Jun 2009, 19:38:33 EDT
- Previously unseen switch regulates breast cancer response to estrogenThu, 8 May 2008, 15:07:32 EDT
- Gene signature helps predict breast cancer prognosisTue, 19 May 2009, 14:15:14 EDT
- 'New' estrogen receptor found to be key player in tamoxifen resistanceThu, 30 Oct 2008, 6:57:00 EDT
- Tamoxifen chemoprevention tied to early detection of breast cancerTue, 7 Oct 2008, 16:36:23 EDT